BAX logo

BAX Baxter International Inc.

$24.36
$0.14
(0.58%)
Today
Closed $24.36
$0.07
(0.29%)
After Hours
54

Neutral Sentiment

How do you feel about BAX?

Loading...
Are Investors Undervaluing Baxter International (BAX) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks
Is Baxter International (BAX) Stock Outpacing Its Medical Peers This Year?
Here is how Baxter International (BAX) and Bayer Aktiengesellschaft (BAYRY) have performed compared to their sector so far this year.
Zacks
Baxter Releases Inaugural Connected Hospital Report
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the release of its 2026 Connected Hospital Report, offering new insights into how hospitals across the United States are leveraging technology investments to drive clinical and operational outcomes. Based on a survey of...
Business Wire
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Zacks
Here's Why You Should Retain Baxter Stock in Your Portfolio for Now
BAX's portfolio reset and growth in connected care and advanced surgery support prospects, but margins, Novum IQ and China pricing remain risks.
Zacks
BAX Raises 2026 Outlook as Strong Q2 Growth Offsets Margin Pressure
Baxter raises its 2026 sales and earnings outlook after strong Q2 growth, though manufacturing costs, tariffs and pricing pressure margins.
Zacks
Baxter Names John Rogers CFO
(RTTNews) - Baxter International Inc. (BAX), a medtech company, on Wednesday said it has appointed John Rogers as executive vice president and chief financial officer (CFO), effective October 1, 2026...
Nasdaq News: Markets
Baxter Appoints John Rogers Chief Financial Officer
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has appointed John Rogers as executive vice president and chief financial officer (CFO), reporting to Baxter president and chief executive officer (CEO), Andrew Hider, effective Oct. 1, 2026. This press release...
Business Wire
Baxter Announces Pricing for Its Upsized Cash Tender Offers
Baxter International Inc. (NYSE:BAX) (Baxter or the Company) today announced the pricing terms for its previously announced cash tender offers (each, an Offer and collectively, the Offers) of the Company's validly tendered (and not validly withdrawn) notes set forth below (the Notes) using a...
Business Wire